<!DOCTYPE html>
<html lang="en-us">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=443&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>publication | Antonio Ahn&#39;s website</title>
    <link rel="stylesheet" href="../css/style.css" />
    <link rel="stylesheet" href="../css/fonts.css" />
    
  </head>

  <body>
    <nav>
    <ul class="menu">
      
      <li><a href="../">Home</a></li>
      
      <li><a href="../posts/">Posts</a></li>
      
      <li><a href="../about/">About</a></li>
      
      <li><a href="../categories/">Categories</a></li>
      
      <li><a href="../tags/">Tags</a></li>
      
      <li><a href="../publication/">Publications</a></li>
      
      <li><a href="../resume/">Resume</a></li>
      
    </ul>
    <hr/>
    </nav>

<div class="article-meta">
<h1><span class="title">publication</span></h1>


</div>

<main>
<ul>
<li>Rodger EJ, Gimenez G, Ajithkumar P, Stockwell PA, Almomani S, Bowden SA, Leichter AL, <strong>Ahn A</strong>, Pattison S, McCall JL, Schmeier S, Frizelle FA, Eccles MR, Purcell RV, Chatterjee A. An epigenetic signature of advanced colorectal cancer metastasis. iScience. 2023 May 28.</li>
<li>Ahmed F, Tseng HY, <strong>Ahn A</strong>, Gunatilake D, Alavi S, Eccles M, Rizos H, Gallagher SJ, Tiffen JC, Hersey P, Emran AA. Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma. J Invest Dermatol. 2022 May</li>
<li>Chatterjee A, Rodger EJ, <strong>Ahn A</strong>, Stockwell PA, Parry M, Motwani J, Gallagher SJ, Shklovskaya E, Tiffen J, Eccles MR, Hersey P: Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma. iScience 2018, 4:312-325.</li>
<li>Chatterjee A, <strong>Ahn A</strong>, Rodger EJ, Stockwell PA, Eccles MR: A Guide for Designing and Analyzing RNA-Seq Data. Methods Mol Biol 2018, 1783:35-80.</li>
<li><strong>Ahn A</strong>, Chatterjee A, Eccles MR: The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma. Mol Cancer Ther 2017, 16:1002-1009.</li>
<li>Chatterjee A, Stockwell PA, <strong>Ahn A</strong>, Rodger EJ, Leichter AL, Eccles MR: Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Oncotarget 2017, 8:6085-6101.</li>
<li>Chatterjee A, Macaulay EC, <strong>Ahn A</strong>, Ludgate JL, Stockwell PA, Weeks RJ, Parry MF, Foster TJ, Knarston IM, Eccles MR, Morison IM: Comparative assessment of DNA methylation patterns between reduced representation bisulfite sequencing and Sequenom EpiTyper methylation analysis. Epigenomics 2017, 9:823-832.</li>
<li>Jones AM, Ferguson P, Gardner J, Rooker S, Sutton T, <strong>Ahn A</strong>, Chatterjee A, Bickley VM, Sarwar M, Emanuel P, et al: NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand. Oncotarget 2016, 7:41017-41030.</li>
<li>Royds JA, Pilbrow AP, <strong>Ahn A</strong>, Morrin HR, Frampton C, Russell IA, Moravec CS, Sweet WE, Tang WH, Currie MJ, et al: The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16 (INK4a) Expression. Front Oncol 2015, 5:306.</li>
<li><strong>Ahn A</strong>, Eccles MR: Targeted therapy; from advanced melanoma to the adjuvant setting. Front Oncol 2013, 3:205.</li>
<li>Eccles MR, He S, <strong>Ahn A</strong>, Slobbe LJ, Jeffs AR, Yoon HS, Baguley BC: MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a &ldquo;Genetic Switch&rdquo; Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma. Front Oncol 2013, 3:229.</li>
<li>Royds JA, Al Nadaf S, Wiles AK, Chen YJ, <strong>Ahn A</strong>, Shaw A, Bowie S, Lam F, Baguley BC, Braithwaite AW, et al: The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival. PLoS One 2011, 6:e26737.</li>
</ul>

</main>

  <footer>
  <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/katex/dist/katex.min.css">
<script src="//cdn.jsdelivr.net/combine/npm/katex/dist/katex.min.js,npm/katex/dist/contrib/auto-render.min.js,npm/@xiee/utils/js/render-katex.js" defer></script>

<script src="//cdn.jsdelivr.net/npm/@xiee/utils/js/center-img.min.js" defer></script>

  
  <hr/>
  <a href="https://github.com/AntonioAhn">Github</a> | <a href="https://twitter.com/AntonioAhnNZ">Twitter</a>
  
  </footer>
  </body>
</html>

